FMP
NASDAQ
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
0.7 USD
-0.03 (-4.29%)
Valuation Date:
Apr 19, 2024 11:03 AM
Share Price on Valuation Date
$0.7
Stock Beta
1.953
Shares Outstanding
987220